
|Articles|July 6, 2015
BioClinica Acquires MediciGroup
Advertisement
BioClinica® announced that it has acquired global patient recruitment and retention firm, MediciGroup. The acquisition includes affiliates MediciGlobal, Ltd. and Access to Patients, LLC. Medici also provides a lost-to-follow-up patient locate service (L2FU®) that finds missing patients globally. The acquisition adds proprietary technologies and processes to BioClinica’s services as well as the ability to integrate recruitment metrics with BioClinica’s system, to help manage clinical trials in real time.
Liz Moench, founder and CEO of Medici, will lead the company’s global patient recruitment and retention services, headquartered at BioClinica’s Philadelphia-area office.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
Breaking the Efficacy Ceiling in IBD and Beyond
4
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
5




